Local targeting of anabolic drug conjugates for treatment of bone loss after tooth extraction
Year: 2017
Type: dissertation
Abstract: Background: Prostaglandin E2 has bone-anabolic effects in vivo but its clinical utility has been hindered by side effects upon systemic administration. A conjugate of an EP4a receptor agonist and a bisphosphonate can circumvent these. Objectives: The aim of the research was to demonstrate the impact of a bone-targeting conjugate on the wound healing and bone formation process. Methods: Molars 1, 2 and 3 of rats were extracted. Treatment groups included bone substitute (BSM) alone, BSM and low dose of conjugate (LD), Bone substitute and high dose of conjugate (HD). Animals were sacrificed after 7, 14 and 28 days. Samples were analyzed via MicroCT, TRAP staining, BSE and Trichrome Goldner staining. Results: All groups showed increase in defect fill. Osteoclast count (OC) and surface area (OCS) were reduced in the HD group after 14 and 28 days. Osteoid formation was elevated in the LD group after 2 and 4 weeks.
Source: TSpace (University of Toronto)
Author: Hendrik Doering
Institution: University of Toronto
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2792792341
